Chemizon Inc. Participates in Crown Bioscience, Inc. Series B Round and Forges a Strategic Alliance  
4/3/2008 9:00:30 AM

LONGMONT, Colo.--(BUSINESS WIRE)--Chemizon, a division of Optomagic (KOSDAQ:010170), through its recently formed private equity fund, announced today that it participated in Crown Bioscience, Inc.’s Series B round of financing. Further, Chemizon and Crown Bioscience, a provider of biology and pharmacology services, have established a strategic partnership that will provide their collaborators with a cost-effective, integrated drug discovery platform focused on generating best-in-class clinical candidates.